| Literature DB >> 24885501 |
Cristina Ovilo1, Rita Benítez, Almudena Fernández, Yolanda Núñez, Miriam Ayuso, Ana Isabel Fernández, Carmen Rodríguez, Beatriz Isabel, Ana Isabel Rey, Clemente López-Bote, Luis Silió.
Abstract
BACKGROUND: The two main genetic types in Iberian pig production show important phenotypic differences in growth, fattening and tissue composition since early developmental stages. The objective of this work was the evaluation of muscle transcriptome profile in piglets of both genetic types, in order to identify genes, pathways and regulatory factors responsible for their phenotypic differences. Contemporary families coming from pure Iberian pigs (IB) or from crossing with Duroc boars (DU×IB) were generated. Piglets (14 from each genetic type) were slaughtered at weaning (28 days) and longissimus dorsi was sampled for composition and gene expression studies. RNA was obtained and hybridized to Affymetrix Porcine Genechip expression arrays.Entities:
Mesh:
Year: 2014 PMID: 24885501 PMCID: PMC4070551 DOI: 10.1186/1471-2164-15-413
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Live weight and muscle fat and fatty acid content in IB and DU×IB piglets at weaning (28d)
| Trait | Iberian (n = 14) | Duroc × Iberian (n = 14) |
|
|---|---|---|---|
| Mean ± SEM | Mean ± SEM | ||
| Live weight (kg) | 8.22 ± 0.37 | 7.85 ± 0.54 | 0.567 |
| Intramuscular fat (g/100 g fresh tissue) | 6.07 ± 0.45 | 4.27 ± 0.43 | 0.009 |
| C16:0, % palmitic acid | 23.15 ± 0.66 | 24.95 ± 0.64 | 0.051 |
| C18:0, % estearic acid | 8.03 ± 0.25 | 9.23 ± 0.24 | 0.001 |
| C18:1n-9, % oleic acid | 38.64 ± 1.28 | 37.05 ± 1.25 | 0.362 |
| C18:2n-6, % linoleic acid | 14.36 ± 0.60 | 15.75 ± 0.68 | 0.095 |
| SFA, % saturated fatty acids | 33.20 ± 0.88 | 36.17 ± 0.86 | 0.019 |
| MUFA, % monounsaturated fatty acids | 47.81 ± 1.55 | 43.42 ± 1.51 | 0.044 |
| PUFA, % polyunsaturated fatty acids | 18.97 ± 0.92 | 20.40 ± 0.90 | 0.259 |
Technical validation of microarray results by qPCR
| Gene | Ratio microarray (DU×IB)/IB |
| ratio qPCR (DU×IB)/IB |
| Correlation ( |
|
|---|---|---|---|---|---|---|
|
| 4.88 | <0.00001 | 2.95 | 0.0001 | 0.796 | <0.0001 |
|
| 3.41 | 0.00001 | 2.41 | 0.0009 | 0.889 | <0.0001 |
|
| 3.35 | 0.00006 | 2.78 | 0.0048 | 0.764 | <0.0001 |
|
| 2.18 | 0.00082 | 2.15 | 0.0060 | 0.540 | 0.0030 |
|
| 1.88 | 0.00009 | 1.76 | 0.012 | 0.744 | <0.0001 |
|
| 1.81 | 0.00111 | 2.00 | 0.019 | 0.832 | <0.0001 |
|
| 1.72 | 0.00071 | 1.58 | 0.019 | 0.506 | 0.0084 |
|
| 1.72 | 0.00005 | 1.60 | 0.025 | 0.794 | <0.0001 |
|
| 0.73 | 0.00541 | 0.65 | 0.046 | 0.444 | 0.0229 |
|
| 0.70 | 0.00139 | 0.78 | 0.128 | 0.189 | 0.3331 |
|
| 0.64 | 0.00216 | 0.54 | 0.084 | 0.869 | <0.0001 |
|
| 0.64 | 0.00114 | 1.11 | 0.561 | 0.086 | 0.6616 |
|
| 0.59 | 0.00369 | 0.82 | 0.358 | 0.502 | 0.0065 |
|
| 0.50 | 0.00028 | 0.57 | 0.024 | 0.802 | <0.0001 |
|
| 0.42 | 0.00017 | 0.42 | 0.074 | 0.769 | <0.0001 |
|
| 0.31 | <0.00001 | 0.37 | 0.001 | 0.787 | <0.0001 |
|
| 0.65 | 0.15186 | 0.50 | 0.030 | 0.866 | <0.0001 |
|
| 1.07 | 0.28406 | 1.13 | 0.433 | 0.255 | 0.2089 |
Functional annotation clustering of genes upregulated in muscle from Iberian piglets
|
|
|
|
|
| GO:0044255 ~ cellular lipid metabolic process | 11 | 0.00007 | PLAA, PTGES3, SAMD8, AGPAT5, ALOX5AP, SCD, EPHX2, PLA1A, GNPAT, ELOVL6, SIRT1 |
| GO:0006644 ~ phospholipid metabolic process | 4 | 0.034 | PLAA, SAMD8, AGPAT5, PLA1A |
| GO:0019637 ~ organophosphate metabolic process | 4 | 0.037 | PLAA, SAMD8, AGPAT5, PLA1A |
|
|
|
|
|
| GO:0006350 ~ transcription | 16 | 0.001 | NFKBIZ, ZFP30, RBM4, AFF4, AFF3, ZNF143, SIRT1, CBFB, MAX, CNTF, ZNF326, IRF1, PHTF1, NFE2L1, DNTTIP2, MLLT3 |
| GO:0006366 ~ transcription from RNA polymerase II promoter | 5 | 0.001 | MAX, AFF4, IRF1, NFE2L1, CBFB |
| GO:0032774 ~ RNA biosynthetic process | 5 | 0.005 | MAX, AFF4, IRF1, NFE2L1, CBFB |
| GO:0006351 ~ transcription, DNA-dependent | 5 | 0.005 | MAX, AFF4, IRF1, NFE2L1, CBFB |
| GO:0045449 ~ regulation of transcription | 19 | 0.007 | NFKBIZ, ZFP30, RBM4, AFF4, AFF3, ZNF143, SIRT1, CBFB, MAX, CNTF, NEDD4, ZNF326, AGT, TIAL1, IRF1, PHTF1, NFE2L1, DNTTIP2, MLLT3 |
|
|
|
|
|
| GO:0006508 ~ proteolysis | 13 | 0.003 | CTSL2, ASB11, MYLIP, C4BPA, UBE2QL1, MARCH6, UBE2D4, CASP4, PSMD11, NEDD4, KLHL15, CASP7, RNF19B |
| GO:0019941 ~ modification-dependent protein catabolic process | 9 | 0.004 | UBE2D4, NEDD4, PSMD11, KLHL15, ASB11, RNF19B, UBE2QL1, MYLIP, MARCH6 |
| GO:0043632 ~ modification-dependent macromolecule catabolic process | 9 | 0.004 | UBE2D4, NEDD4, PSMD11, KLHL15, ASB11, RNF19B, UBE2QL1, MYLIP, MARCH6 |
| GO:0051603 ~ proteolysis involved in cellular protein catabolic process | 9 | 0.005 | UBE2D4, NEDD4, PSMD11, KLHL15, ASB11, RNF19B, UBE2QL1, MYLIP, MARCH6 |
| GO:0044257 ~ cellular protein catabolic process | 9 | 0.005 | UBE2D4, NEDD4, PSMD11, KLHL15, ASB11, RNF19B, UBE2QL1, MYLIP, MARCH6 |
| GO:0030163 ~ protein catabolic process | 9 | 0.007 | UBE2D4, NEDD4, PSMD11, KLHL15, ASB11, RNF19B, UBE2QL1, MYLIP, MARCH6 |
| GO:0009057 ~ macromolecule catabolic process | 10 | 0.008 | NGLY1, UBE2D4, NEDD4, PSMD11, KLHL15, ASB11, RNF19B, UBE2QL1, MYLIP, MARCH6 |
| GO:0044265 ~ cellular macromolecule catabolic process | 9 | 0.014 | UBE2D4, NEDD4, PSMD11, KLHL15, ASB11, RNF19B, UBE2QL1, MYLIP, MARCH6 |
+ P-value from modified Fisher exact score.
Functional annotation clustering of genes upregulated in muscle from DU×IB piglets
| Annotation Cluster 1 Enrichment Score: 6.94 | Count |
| Genes |
|---|---|---|---|
| GO:0032501 ~ multicellular organismal process | 54 | 6.61E-13 | S100A6, AEBP1, KERA, UTRN, POSTN, REST, ENPEP, GPX2, APP, ROBO1, SEMA3E, S1PR5, COL12A1, LOX, SLC22A2, USH2A, EGFL6, CHODL, CTNNBIP1, MAN2A1, ALDH7A1, DACT1, GRN, SORT1, VCAN, COL1A1, CNTN3, PROS1, CASQ2, MYL6, HUS1, AKAP9, GPM6B, FKBP1A, APLNR, PTK2, ITGAV, SYN3, PPP3CB, SCARB1, FBN2, DCLK1, MAP1B, ITGA2, IGF2, COL5A1, DKK3, ITGA6, SFRP2, CD59, TCF12, MYH10, CDH11, CLCN5 |
| GO:0048856 ~ anatomical structure development | 41 | 9.60E-10 | MYL6, AEBP1, S100A6, UTRN, GPM6B, POSTN, FKBP1A, ENPEP, REST, PTK2, APP, ROBO1, ITGAV, S1PR5, SEMA3E, PPP3CB, COL12A1, FBN2, LOX, USH2A, DCLK1, MYOC, MAP1B, CHODL, ITGA2, IGF2, COL5A1, DKK3, MAN2A1, ITGA6, SFRP2, GRN, SORT1, VCAN, ANTXR1, CNTN3, COL1A1, TCF12, CASQ2, MYH10, CDH11 |
| GO:0007275 ~ multicellular organismal development | 43 | 2.42E-09 | MYL6, AEBP1, S100A6, HUS1, UTRN, GPM6B, POSTN, FKBP1A, ENPEP, REST, PTK2, APP, ROBO1, ITGAV, S1PR5, SEMA3E, PPP3CB, COL12A1, FBN2, LOX, USH2A, DCLK1, EGFL6, MAP1B, CHODL, ITGA2, IGF2, COL5A1, CTNNBIP1, DKK3, MAN2A1, DACT1, ITGA6, SFRP2, GRN, SORT1, VCAN, CNTN3, COL1A1, TCF12, CASQ2, MYH10, CDH11 |
| GO:0032502 ~ developmental process | 45 | 4.28E-09 | MYL6, S100A6, AEBP1, HUS1, UTRN, GPM6B, POSTN, FKBP1A, ENPEP, REST, PTK2, APP, ROBO1, ITGAV, S1PR5, SEMA3E, PPP3CB, COL12A1, FBN2, LOX, USH2A, DCLK1, MYOC, EGFL6, MAP1B, CHODL, ITGA2, IGF2, COL5A1, CTNNBIP1, DKK3, MAN2A1, DACT1, ITGA6, SFRP2, GRN, SORT1, VCAN, ANTXR1, CNTN3, COL1A1, TCF12, CASQ2, MYH10, CDH11 |
| GO:0048731 ~ system development | 35 | 1.36E-07 | MYL6, AEBP1, S100A6, UTRN, GPM6B, POSTN, FKBP1A, ENPEP, REST, APP, PTK2, ROBO1, ITGAV, S1PR5, SEMA3E, PPP3CB, COL12A1, LOX, USH2A, DCLK1, MAP1B, CHODL, ITGA2, IGF2, COL5A1, MAN2A1, ITGA6, SORT1, VCAN, CNTN3, COL1A1, TCF12, CASQ2, CDH11, MYH10 |
| GO:0030154 ~ cell differentiation | 22 | 2.12E-04 | S100A6, EGFL6, UTRN, MAP1B, ITGA2, IGF2, GPM6B, REST, PTK2, APP, ITGA6, ROBO1, SFRP2, SEMA3E, S1PR5, PPP3CB, SORT1, VCAN, ANTXR1, COL1A1, DCLK1, MYH10 |
| GO:0048869 ~ cellular developmental process | 22 | 3.88E-04 | S100A6, EGFL6, UTRN, MAP1B, ITGA2, IGF2, GPM6B, REST, PTK2, APP, ITGA6, ROBO1, SFRP2, SEMA3E, S1PR5, PPP3CB, SORT1, VCAN, ANTXR1, COL1A1, DCLK1, MYH10 |
| GO:0048513 ~ organ development | 24 | 4.09E-04 | MYL6, AEBP1, UTRN, ITGA2, CHODL, FKBP1A, IGF2, POSTN, ENPEP, COL5A1, MAN2A1, PTK2, APP, ITGA6, ROBO1, ITGAV, PPP3CB, COL1A1, LOX, TCF12, CASQ2, USH2A, DCLK1, MYH10 |
|
|
|
|
|
| GO:0043062 ~ extracellular structure organization | 11 | 7.37E-08 | APP, PTK2, COL14A1, UTRN, MAP1B, COL12A1, FKBP1A, POSTN, COL1A1, LOX, COL5A1 |
| GO:0030198 ~ extracellular matrix organization | 9 | 5.04E-07 | APP, PTK2, COL14A1, COL12A1, FKBP1A, POSTN, COL1A1, LOX, COL5A1 |
| GO:0030199 ~ collagen fibril organization | 5 | 7.49E-05 | COL14A1, COL12A1, COL1A1, LOX, COL5A1 |
|
|
|
|
|
| GO:0009605 ~ response to external stimulus | 15 | 1.56E-04 | MAP1B, ITGA2, IGF2, ENSA, COL5A1, ITGA6, SFRP2, ROBO1, CD59, SCARB1, VCAN, LOX, COL1A1, PROS1, MYH10 |
| GO:0042060 ~ wound healing | 8 | 2.23E-04 | CD59, ITGA2, SCARB1, IGF2, LOX, PROS1, COL5A1, MYH10 |
| GO:0009611 ~ response to wounding | 10 | 0.0011093 | CD59, MAP1B, ITGA2, VCAN, SCARB1, IGF2, LOX, PROS1, COL5A1, MYH10 |
| GO:0051128 ~ regulation of cellular component organization | 9 | 0.011086 | PTK2, ROBO1, MAP1B, ITGA2, SCARB1, IGF2, COL5A1, MYH10, DSTN |
| GO:0050896 ~ response to stimulus | 28 | 0.0134512 | KERA, HUS1, TIPIN, FKBP1A, ENSA, GPX2, APP, ROBO1, PPP3CB, SCARB1, GNG2, LOX, FAM129A, USH2A, MAP1B, ITGA2, IGF2, COL5A1, ABCG2, ITGA6, SFRP2, CD59, SORT1, VCAN, COL1A1, TCF12, PROS1, MYH10 |
| GO:0042221 ~ response to chemical stimulus | 14 | 0.0284588 | MAP1B, ITGA2, FKBP1A, IGF2, ENSA, ABCG2, GPX2, ROBO1, PPP3CB, SORT1, SCARB1, GNG2, LOX, COL1A1 |
|
|
|
|
|
| GO:0006928 ~ cell motion | 13 | 1.17E-05 | ITGA2, ENPEP, COL5A1, DSTN, PTK2, APP, ITGA6, ROBO1, SCARB1, VCAN, DCLK1, THBS4, MYH10 |
| GO:0016477 ~ cell migration | 10 | 1.09E-04 | PTK2, ITGA6, ROBO1, VCAN, SCARB1, ENPEP, COL5A1, DCLK1, MYH10, THBS4 |
| GO:0007409 ~ axonogenesis | 8 | 1.21E-04 | APP, S100A6, PTK2, ROBO1, MAP1B, VCAN, DCLK1, MYH10 |
| GO:0000904 ~ cell morphogenesis involved in differentiation | 9 | 1.61E-04 | APP, S100A6, PTK2, ROBO1, MAP1B, VCAN, ANTXR1, DCLK1, MYH10 |
| GO:0048870 ~ cell motility | 10 | 1.61E-04 | PTK2, ITGA6, ROBO1, VCAN, SCARB1, ENPEP, COL5A1, DCLK1, MYH10, THBS4 |
| GO:0051674 ~ localization of cell | 10 | 1.64E-04 | PTK2, ITGA6, ROBO1, VCAN, SCARB1, ENPEP, COL5A1, DCLK1, MYH10, THBS4 |
| GO:0030154 ~ cell differentiation | 22 | 2.12E-04 | S100A6, EGFL6, UTRN, MAP1B, ITGA2, IGF2, GPM6B, REST, PTK2, APP, ITGA6, ROBO1, SFRP2, SEMA3E, S1PR5, PPP3CB, SORT1, VCAN, ANTXR1, COL1A1, DCLK1, MYH10 |
| GO:0009653 ~ anatomical structure morphogenesis | 20 | 2.24E-04 | S100A6, MAP1B, ITGA2, FKBP1A, IGF2, ENPEP, COL5A1, DKK3, PTK2, APP, ITGA6, ROBO1, SFRP2, VCAN, ANTXR1, FBN2, COL1A1, MYOC, DCLK1, MYH10 |
| GO:0048869 ~ cellular developmental process | 22 | 3.88E-04 | S100A6, EGFL6, UTRN, MAP1B, ITGA2, IGF2, GPM6B, REST, PTK2, APP, ITGA6, ROBO1, SFRP2, SEMA3E, S1PR5, PPP3CB, SORT1, VCAN, ANTXR1, COL1A1, DCLK1, MYH10 |
| GO:0030030 ~ cell projection organization | 10 | 5.27E-04 | APP, S100A6, PTK2, ITGA6, ROBO1, MAP1B, VCAN, DCLK1, MYH10, THBS4 |
| GO:0040011 ~ locomotion | 10 | 5.63E-04 | PTK2, ITGA6, ROBO1, VCAN, SCARB1, ENPEP, COL5A1, DCLK1, MYH10, THBS4 |
| GO:0048858 ~ cell projection morphogenesis | 8 | 5.68E-04 | APP, S100A6, PTK2, ROBO1, MAP1B, VCAN, DCLK1, MYH10 |
| GO:0032990 ~ cell part morphogenesis | 8 | 9.16E-04 | APP, S100A6, PTK2, ROBO1, MAP1B, VCAN, DCLK1, MYH10 |
| GO:0000902 ~ cell morphogenesis | 9 | 0.0013059 | APP, S100A6, PTK2, ROBO1, MAP1B, VCAN, ANTXR1, DCLK1, MYH10 |
| GO:0048699 ~ generation of neurons | 10 | 0.0021025 | APP, S100A6, PTK2, ROBO1, S1PR5, MAP1B, VCAN, REST, DCLK1, MYH10 |
| GO:0048666 ~ neuron development | 8 | 0.0025921 | APP, S100A6, PTK2, ROBO1, MAP1B, VCAN, DCLK1, MYH10 |
| GO:0022008 ~ neurogenesis | 10 | 0.0031988 | APP, S100A6, PTK2, ROBO1, S1PR5, MAP1B, VCAN, REST, DCLK1, MYH10 |
| GO:0032989 ~ cellular component morphogenesis | 9 | 0.0032876 | APP, S100A6, PTK2, ROBO1, MAP1B, VCAN, ANTXR1, DCLK1, MYH10 |
| GO:0045664 ~ regulation of neuron differentiation | 5 | 0.0042345 | PTK2, ROBO1, S1PR5, MAP1B, REST |
| GO:0007399 ~ nervous system development | 13 | 0.0054731 | S100A6, MAP1B, GPM6B, REST, PTK2, APP, ROBO1, S1PR5, SEMA3E, VCAN, CNTN3, DCLK1, MYH10 |
| GO:0048468 ~ cell development | 11 | 0.005626 | APP, S100A6, PTK2, ROBO1, UTRN, MAP1B, PPP3CB, VCAN, ANTXR1, DCLK1, MYH10 |
| GO:0030182 ~ neuron differentiation | 8 | 0.0057725 | APP, S100A6, PTK2, ROBO1, MAP1B, VCAN, DCLK1, MYH10 |
| GO:0060284 ~ regulation of cell development | 6 | 0.0067586 | PTK2, ROBO1, S1PR5, MAP1B, IGF2, REST |
| GO:0050767 ~ regulation of neurogenesis | 5 | 0.0122736 | PTK2, ROBO1, S1PR5, MAP1B, REST |
| GO:0031344 ~ regulation of cell projection organization | 4 | 0.0132242 | PTK2, ROBO1, MAP1B, ITGA2 |
| GO:0051960 ~ regulation of nervous system development | 5 | 0.0177634 | PTK2, ROBO1, S1PR5, MAP1B, REST |
| GO:0045595 ~ regulation of cell differentiation | 8 | 0.0186936 | PTK2, ROBO1, ITGAV, S1PR5, MAP1B, IGF2, REST, USH2A |
| GO:0022604 ~ regulation of cell morphogenesis | 4 | 0.037216 | PTK2, ROBO1, MAP1B, MYH10 |
| GO:0050793 ~ regulation of developmental process | 9 | 0.0379454 | PTK2, ROBO1, ITGAV, S1PR5, MAP1B, IGF2, REST, USH2A, MYH10 |
+ P-value from modified Fisher exact score.
Figure 1Functional categorization analysis with IPA. Canonical pathways significantly enriched in the three sets of genes are shown (P < 0.05): A) Genes DE between both genetic types; B) Genes upregulated in IB; C) Genes upregulated in DU×IB. Signaling pathways are indicated with dark bars and metabolic pathways with light bars.
Figure 2Gene network 1: Cellular Development, Cellular Growth and Proliferation, Embryonic Development (score 51). Molecules are represented as nodes and the biological relationships between nodes are represented as edges. Genes upregulated in IB are indicated in red and the ones upregulated in DU×IB are shown in green.
Figure 3Gene network 2: Connective Tissue Disorders, Dermatological Diseases and Conditions, Cellular Assembly and Organization (score 47). Molecules are represented as nodes and the biological relationships between nodes are represented as edges. Genes upregulated in IB are indicated in red and the ones upregulated in DU×IB are shown in green.
Figure 4Gene network 3: Protein Degradation, Protein Synthesis, Cell Morphology (score 41). Molecules are represented as nodes and the biological relationships between nodes are represented as edges. Genes upregulated in IB are indicated in red and the ones upregulated in DU×IB are shown in green.
RIF prediction for regulatory factors in the whole dataset of DE genes
|
|
|
|
|
|
|---|---|---|---|---|
| Ssc.10025.3.S1_at |
| CCAAT/enhancer binding protein (C/EBP). delta | -3.152 | -0.017 |
| Ssc.1012.1.S1_at |
| zinc finger protein 277 | -1.251 | 2.751 |
| Ssc.10128.1.A1_at |
| SIX homeobox 4 | -2.986 | 3.127 |
| Ssc.13567.1.A1_at |
| zinc fingers and homeoboxes 2 | -0.921 | 3.454 |
| Ssc.14573.1.S1_at |
| Eyes absent homolog 2 | -2.907 | 3.048 |
| Ssc.16976.1.S1_at |
| Sterol regulatory element binding transcription factor 2 | -0.970 | 2.533 |
| Ssc.19163.1.S1_at |
| MAX interactor 1. dimerization protein | -1.860 | 3.443 |
| Ssc.19313.1.A1_at |
| MYC associated factor X | -3.270 | -1.671 |
| Ssc.19537.1.S1_at |
| Interferon regulatory factor 2 | -2.701 | -0.615 |
| Ssc.2001.1.A1_at |
| LIM homeobox 6 | -1.383 | -2.847 |
| Ssc.21096.1.S1_at |
| Paired box 2 | -0.895 | 2.378 |
| Ssc.22470.1.S1_at |
| Period circadian clock 3 | -2.258 | 0.824 |
| Ssc.23498.1.S1_s_at |
| Myostatin | -1.930 | 2.582 |
| Ssc.24606.1.A1_a_at |
| Peroxisome proliferator-activated receptor gamma coactivator 1 beta | -2.896 | 0.167 |
| Ssc.26039.1.S1_at |
| RAR-related orphan receptor A | -3.597 | 1.736 |
| Ssc.2719.1.A1_at |
| Metastasis associated 1 family, member 3 | -1.805 | -2.555 |
| Ssc.27410.1.S1_at |
| v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog | -2.823 | -0.783 |
| Ssc.27576.1.S1_at |
| Meningioma (disrupted in balanced translocation) 1 | -2.263 | -0.086 |
| Ssc.27622.1.S1_at |
| Kruppel-like factor 11 | -3.789 | 2.701 |
| Ssc.27964.2.S1_at |
| GATA binding protein 3 | 0.063 | -2.061 |
| Ssc.29855.1.A1_at |
| Cell division cycle associated 7 | -2.346 | 0.220 |
| Ssc.30288.1.A1_at |
| Grainyhead-like 3 (Drosophila) | 0.489 | -2.038 |
| Ssc.30799.1.A1_at |
| Dachshund family transcription factor 1 | 0.772 | -2.329 |
| Ssc.3355.1.S1_at |
| Histone deacetylase 1 | 0.747 | -1.971 |
| Ssc.4212.1.A1_at |
| ELK3, ETS-domain protein (SRF accessory protein 2) | -2.349 | -1.032 |
| Ssc.6697.1.S1_at |
| SRY (sex determining region Y)-box 4 | -3.143 | -0.718 |
| Ssc.8529.1.A1_at |
| ZFP36 ring finger protein-like 1 | -3.282 | 1.299 |
| Ssc.9136.1.S1_at |
| CCR4 carbon catabolite repression 4-like (S. cerevisiae) | -1.056 | -2.354 |
| Ssc.9298.1.A1_at |
| Iroquois homeobox 3 | -2.538 | -0.692 |
§Bootstrap 99% and 95% confidence intervals for RIF1 z-scores: -3.288/2.754 and -2.155/1.898, respectively.
λBootstrap 99% and 95% confidence intervals for RIF2 z-scores: -2.594/3.007 and -1.966/2.030, respectively.
Information on the primer pairs used for quantitative real-time PCR analysis
| Gene symbol | Gene name | Genbank Acc. number | Primer sequences 5′-3′ | Amplicon size (bp) |
|
|---|---|---|---|---|---|
|
| Insulin-like growth factor 2 | NM213883 | GCCGCTGCTCGTGCTGCTCGTCTT | 151 | 86 |
| GCTTGCCGGCCTGCTGAA | |||||
|
| Keratocan | XM001927128 | GTGGCCTTCCTGAGACTAAACC | 198 | 89 |
| AGGGCATATCACAGAGACATTCAC | |||||
|
| Fibromodullin | XM003130105 | GCTGCTATATGTGCGGCTGTC | 194 | 93 |
| AGAAACTGCTAATGGAGAACT | |||||
|
| Collagen alpha-1 | EF136662 | AGCCCAGCGTGCCCCAGAAGAA | 164 | 88 |
| ACATCAGGCGCAGGAAGGTCAGC | |||||
|
| Fibrillin 2 | XM003123897 | GGACGCTGCATACCTACTGT | 201 | 96 |
| AATGCATGCTTGCTTGGTAGG | |||||
|
| AE binding protein 1 | XM003134886 | CGGCGGCATGGGCATCGTCAAC | 233 | 90 |
| TGCCCTGCTCGTCCGTCACTACCC | |||||
|
| Lysyl oxidase | NM001206403 | CTGAGATGCGCTGCGGAGGAAAAC | 223 | 88 |
| TGGCATCAAGCAGGTCGTAGTGG | |||||
|
| FK506 binding protein 14 | XM005673279 | TTCCGGAACTTCTTTCCTGCTCT | 250 | 91 |
| GGCTGACCATTGTTATGTTTGTGA | |||||
|
| Proteasome 26S subunit, non-ATPase | XM003131741 | TCTTACGCCAGGCTTTGGAG | 219 | 91 |
| CTGTGGTTCGAGCAGAGGTT | |||||
|
| Arachidonate 5-lipoxygenase-activating protein | NM001164001 | TGGACTGATGTACCTGTTTGTGAG | 213 | 94 |
| AGAGGGGAGACGGTGGTGGTGA | |||||
|
| Caspase 4 | XM003129812 | AATATGCTTGGCGCTGTCAC | 190 | 97 |
| TGGTGCTTCTCGAAGTTGGT | |||||
|
| Fatty acid elongase 6 | XR305072 | AGAACACGTAGCGACTCCGAAGAT | 182 | 96 |
| GACATGCCGACCGCCAAAGATAA | |||||
|
| NF-kappa-B inhibitor zeta-like | XM003132694 | TATGATGGCCTGACTCCTCTACAC | 196 | 91 |
| TGCGGCCACTTTTACGAT | |||||
|
| Malic Enzyme | XM001924333 | TTTCCTGGAGTTGCCCTTGGTGT | 213 | 90 |
| GGTGGCTGTCTTTTCTTGGTATGC | |||||
|
| Phospholipase A1 member A | XM003483312 | TGTGGGCAGCTAGTGGAAGAAAGT | 215 | 91 |
| TCCACGGCTGAAAAGTAGACACC | |||||
|
| Paraoxonase 3 | HQ542303 | ACGGGAGATATTTGGGCAGG | 142 | 92 |
| TGTTGGCATACTCGGTGCTT | |||||
|
| Stearoyl-CoA desaturase | JN613287 | TCCCGACGTGGCTTTTTCTTCTC | 205 | 90 |
| CTTCACCCCAGCAATACCAG | |||||
|
| Fatty acid elongase 5 | ENSSSCG00000024149 | CTTGCCGGGGGATTTTGGTTG | 223 | 82 |
| TTGCGCAGGATGAAGAAGAAGGTG | |||||
|
| Delta-like 1 homolog | NM_001048187 | CGGGCCCTGCGTGATGAATGG | 208 | 83 |
| AGGGCAGCGGCAGCGGAAGTC |